Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S27 pseudogene 27 (RPS27P27) is a **processed, non-coding pseudogene** of the gene encoding ribosomal protein S27. Unlike the parent RPS27 gene, which encodes a component of the 40S ribosomal subunit important in protein synthesis and has been implicated as an oncogene and a cancer biomarker, RPS27P27 itself is not transcribed or translated into a functional protein and does not participate in cellular processes or disease pathogenesis[3][6]. Multiple processed pseudogenes of ribosomal proteins, including RPS27, exist in the human genome; however, these pseudogenes generally lack coding capacity and are not considered therapeutic or drug targets[3][6].\n\n**Key points and explanations:**\n- RPS27P27 is listed in gene databases as a pseudogene, not as a functional gene or protein[3][6].\n- Pseudogenes do not produce proteins and do not have established biological functions or roles in disease; they are not therapeutic targets.\n- While *RPS27* gene (not the pseudogene) encodes a protein component of the ribosome and is involved in cancer biology, RPS27P27 does not encode this or any other protein[1][5].\n\n**Incorrectness explanation:**\nRPS27P27 is not a **therapeutically relevant target**, nor does it encode a protein, enzyme, receptor, transporter, or any functional molecule. Any confusion may arise from the similarity of its name to the functional gene RPS27. This target is a pseudogene and not suitable as a canonical therapeutic target[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S27 pseudogene 27 (RPS27P27).